Sabrina A. Assoumou - Concepedia

Author

Sabrina A. Assoumou

Also Known As

Assoumou, Sabrina A., S A Assoumou, S. A. Assoumou, S.A. Assoumou, SABRINA A. ASSOUMOU, Sabrina A Assoumou, Sabrina A. Assoumou, Sabrina Assoumou

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Boston University Boston Medical Center Cornell University Brown University Fenway Health

About

Sabrina A. Assoumou is an author at Boston University specializing in medicine, public health, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	267
2	Public Health	7	7	267
3	Health Sciences	3	3	89
4	Health Policy	3	3	210
5	Epidemiology	2	2	27

Sabrina A. Assoumou

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Long COVID and Health Inequities: The Role of Primary Care Zackary Berger, Vivian Valeria Altiery De Jesus, Sabrina A. Assoumou, Milbank Quarterly Disease ManagementPrimary CarePreventive MedicineLong CovidHealth Policy	2021	135
The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes Benjamin P. Linas, Devra M. Barter, Jared A. Leff, PLoS ONE	2014	124
The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection Benjamin P. Linas, Devra M. Barter, Jake R. Morgan, Annals of Internal Medicine	2015	107
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings Sabrina A. Assoumou, Abriana Tasillo, Jared A. Leff, Clinical Infectious Diseases	2017	82
Projected Estimates of Opioid Mortality After Community-Level Interventions Benjamin P. Linas, Alexandra Savinkina, R. W. M. A. Madushani, JAMA Network Open	2021	71
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge Pranay Sinha, Anahita Mostaghim, Catherine Bielick, International Journal of Infectious Diseases	2020	67
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort Jake R. Morgan, Alexander Y. Walley, Sean M. Murphy, Drug and Alcohol Dependence Opioid EpidemicInsured CohortSubstance AbuseSubstance UseHealth Policy	2021	56
Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons Sabrina A. Assoumou, Abriana Tasillo, Claudia Vellozzi, Clinical Infectious Diseases	2019	35
The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients Benjamin P. Linas, Devra M. Barter, Jared A. Leff, AIDS	2013	29
Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic Leah Harvey, Jessica L. Taylor, Sabrina A. Assoumou, Journal of Addiction Medicine	2021	26

Page 1